Declan has over 30 years of industry experience in both major pharma and biotech. 

He served as Head of Worldwide Development at Pfizer, where many multi-billion-dollar programs were delivered, including Viagra, Lipitor and Zoloft. After leaving Pfizer, Declan went on to serve in a number of executive roles in small pharma. Later, Declan served as CMO and acting CEO of Amarin (AMRN: Nasdaq), and then went on to co-found Biohaven (BHVN: NYSE). At Causeway, Declan directs the Company’s strategic direction and oversees operational activities.

Declan is also an investor in emerging biotechnology companies. He holds a number of board appointments, principally in pharma companies, and has also served as Visiting Professor at Glasgow University Medical School. He is a Fellow of the Royal College of Physicians and earned his medical degree from Glasgow University and his D.Sc. from the University of Kent.